Description
Retatrutide is an investigational synthetic peptide and first-in-class triple agonist of the GIP, GLP-1, and glucagon receptors. It is being studied for its potential effects on weight management, glycemic control, and metabolic function in preclinical and clinical research. Retatrutide represents a novel approach to multi-receptor targeting in metabolic research. Supplied as a lyophilized powder for laboratory research use only.
Reviews
There are no reviews yet.